Literature DB >> 17652894

Ratio of early transmitral velocity to lateral mitral annular early diastolic velocity has the best correlation with wedge pressure following cardiac surgery.

Yasuyuki Hadano1, Kazuya Murata, Nobuaki Tanaka, Aiko Muro, Eizo Akagawa, Takeo Tanaka, Hideki Kunichika, Masunori Matsuzaki.   

Abstract

BACKGROUND: Although previous investigators reported that mitral annular velocity predicts mean pulmonary capillary wedge pressure (PCWP), it is unknown whether the lateral or septal mitral annular velocity more faithfully predicts PCWP after cardiac surgery. METHODS AND
RESULTS: To assess the effect of cardiac surgery on the predictive values for PCWP by measuring mitral annular velocity, 52 consecutive patients undergoing cardiac surgery were studied. All patients underwent transthoracic echocardiography and right-sided cardiac catheterization both before and after surgery. The peak early diastolic velocity of transmitral flow (E) was measured by pulsed-wave Doppler and the peak early diastolic velocities of the lateral (LEa) and septal (SEa) mitral annulus by pulsed-wave tissue Doppler imaging. The ratios of E to LEa (E/LEa) and SEa (E/SEa) were calculated. Immediately after echocardiography, PCWP was measured using a balloon-tipped pulmonary artery catheter. After surgery, LEa was significantly increased (6.4+/-2.7 vs 8.6+/-3.3 cm/s, p<0.001), but SEa was unchanged (6.0+/-2.5 vs 5.5+/-2.3 cm/s, p=0.09). E/LEa correlated well with PCWP both before and after surgery (r=0.79 and r=0.69, respectively, p<0.001). Although E/SEa correlated well before surgery (r=0.67, p<0.001), it correlated only weakly after surgery (r=0.44, p<0.01).
CONCLUSIONS: E/LEa has the best correlation with PCWP both before and after cardiac surgery and may be more useful than E/SEa in the noninvasive estimation of PCWP.

Entities:  

Mesh:

Year:  2007        PMID: 17652894     DOI: 10.1253/circj.71.1274

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  7 in total

1.  Impact of surgical ventricular reconstruction for ischemic dilated cardiomyopathy on restrictive filling pattern.

Authors:  Yasuhiro Shudo; Goro Matsumiya; Taichi Sakaguchi; Shigeru Miyagawa; Takashi Yamauchi; Koji Takeda; Shunsuke Saito; Kazuhiro Taniguchi; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-08-12

2.  Noninvasive assessment of exercise tolerance using mitral annular velocities.

Authors:  Yasuyuki Hadano; Masunori Matsuzaki
Journal:  J Med Ultrason (2001)       Date:  2015-09-16       Impact factor: 1.314

3.  Left ventricular filling pressure by septal and lateral E/e' equally predict cardiovascular events in the general population.

Authors:  Joanna Nan Wang; Tor Biering-Sørensen; Peter Godsk Jørgensen; Jan Skov Jensen; Rasmus Mogelvang
Journal:  Int J Cardiovasc Imaging       Date:  2017-01-09       Impact factor: 2.357

4.  Prognostic value of tissue Doppler-Derived E/e' on early morbid events after cardiac surgery.

Authors:  Leanne Groban; David M Sanders; Timothy T Houle; Benjamin L Antonio; Edi C Ntuen; David A Zvara; Neal D Kon; Edward H Kincaid
Journal:  Echocardiography       Date:  2010-02       Impact factor: 1.724

5.  Impact of milrinone on mitral annular velocity in patients with congestive heart failure.

Authors:  Yasuyuki Hadano; Hiroshi Ogawa; Takatoshi Wakeyama; Akira Takaki; Takahiro Iwami; Masayasu Kimura; Mamoru Mochizuki; Yosuke Miyazaki; Atsushi Hiratsuka; Masunori Matsuzaki
Journal:  J Med Ultrason (2001)       Date:  2012-10-10       Impact factor: 1.314

Review 6.  Diastolic dysfunction, cardiovascular aging, and the anesthesiologist.

Authors:  David Sanders; Michael Dudley; Leanne Groban
Journal:  Anesthesiol Clin       Date:  2009-09

Review 7.  What Is the Evidence That the Tissue Doppler Index E/e' Reflects Left Ventricular Filling Pressure Changes After Exercise or Pharmacological Intervention for Evaluating Diastolic Function? A Systematic Review.

Authors:  Oleg F Sharifov; Himanshu Gupta
Journal:  J Am Heart Assoc       Date:  2017-03-15       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.